See a Demo

Transparent Thinking Blog

TrialAssure cubes divider
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: June 8 – June 14, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Outsourcing-Pharma released a State of the Industry report that sheds light on the global pharmaceutical industry. One of the key findings in the report showed that more than half of survey respondents believe that industry initiatives will lead to greater transparency. The report points to a new pilot program launched earlier this year by the FDA to increase transparency. Clinical Trial Transparency Software client feedback

This week in transparency news: June 1 – June 7, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Federal Office for Safety in Health Care (BASG) vienna austria trialassure clinical trial registration disclosure transparency

REGISTRY SNAPSHOT: Federal Office for Safety in Health Care (BASG)

by Staff Writer | June 2019

Posted in Snapshots
Read More
CSR pilot FDA releases first clinical study report in data transparency pilot program trialassure fdaaa section 801 requirements fdaaa trials tracker

This week in transparency news: May 25 – May 31, 2019

by Staff Writer | May 2019

Posted in Blog
Read More
National Registry of Health Research (ReNIS) argentina clinical trial registration disclosure trialassure

REGISTRY SNAPSHOT: National Registry of Health Research (ReNIS)

by Staff Writer | May 2019

Posted in Snapshots
Read More
Should people share their DNA for drug development purposes? – USA Today Many people don’t realize that sharing a DNA sample with Ancestry.com, 23andMe and others can result in their data being shared. However, this week, the companies pledged that they would disclose when data is shared with corporations or the government. With a $300 million investment by GSK in 23andMe, they state that approximately 80 percent of customers have agreed to share their DNA data. This data is being de-identified before it is shared.

This week in transparency news: May 18 – May 24, 2019

by Staff Writer | May 2019

Posted in Blog
Read More
Federal Commission for Protection Against Sanitary Risk (COFEPRIS) mexico trialassure clinical trial registration disclosure registry support services help assistance expert technology pharmatech medtech trialassure

REGISTRY SNAPSHOT: Federal Commission for Protection Against Sanitary Risk (COFEPRIS)

by Staff Writer | May 2019

Posted in Snapshots
Read More

This week in transparency news: May 11 – May 17, 2019

by Staff Writer | May 2019

Posted in Blog
Read More
National Institute of Pharmacy and Nutrition (OGYEI) budapest hungary trialassure

REGISTRY SNAPSHOT: National Institute of Pharmacy and Nutrition (OGYEI)

by Staff Writer | May 2019

Posted in Snapshots
Read More
lay summaries pls plain language summary trialassure

This Week in Transparency News: May 4 – May 10, 2019

by Staff Writer | May 2019

Posted in Blog
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.

  • *